Maravai Lifesciences Holdings (MRVI) Gross Margin Growth (1y) (2021 - 2026)

Maravai Lifesciences Holdings (MRVI) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Maravai Lifesciences Holdings 1.03 Bn 1.02 Bn 33.70 Mn 3,470.00

Historic Data

Download Data
DateValue
Mar 31, 2026 3,470.00
Dec 31, 2025 -853.00
Sep 30, 2025 -3,312.00
Jun 30, 2025 -2,804.00
Mar 31, 2025 -2,378.00
Dec 31, 2024 -1,836.00
Sep 30, 2024 156.00
Jun 30, 2024 722.00
Mar 31, 2024 -1,712.00
Dec 31, 2023 -2,134.00
Sep 30, 2023 -3,491.00
Jun 30, 2023 -4,735.00
Mar 31, 2023 -2,623.00
Dec 31, 2022 -888.00
Sep 30, 2022 -423.00
Jun 30, 2022 191.00
Mar 31, 2022 479.00
Dec 31, 2021 665.00
Sep 30, 2021 676.00
Jun 30, 2021 2,783.00